华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002007 华兰生物

已收盘 01-13 15:00:00

{"stockData":{"symbol":"002007","market":"SZ","secType":"STK","nameCN":"华兰生物","latestPrice":15.7,"timestamp":1768287816000,"preClose":15.58,"halted":0,"volume":23205106,"delay":0,"changeRate":0.0077,"floatShares":1574000000,"shares":1827000000,"eps":0.5191,"marketStatus":"已收盘","change":0.12,"latestTime":"01-13 15:00:00","open":15.61,"high":15.88,"low":15.55,"amount":365000000,"amplitude":0.0212,"askPrice":15.7,"askSize":373,"bidPrice":15.69,"bidSize":405,"shortable":0,"etf":0,"ttmEps":0.5191,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":15.58,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":17.14,"lowLimit":14.02,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1827456666,"isCdr":false,"pbRate":2.5,"roa":"--","peRate":30.244654,"roe":"6.55%","epsLYR":0.5958,"committee":0.241544,"marketValue":28691000000,"turnoverRate":0.0147,"status":0,"floatMarketCap":24707000000},"requestUrl":"/m/hq/s/002007","defaultTab":"news","newsList":[{"id":"2602232545","title":"华兰生物（002007）披露参股公司收到药品注册受理通知书，1月12日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602232545","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602232545?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:19","pubTimestamp":1768227557,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，华兰生物报收于15.58元，较前一交易日下跌0.45%，最新总市值为284.72亿元。该股当日开盘15.65元，最高15.66元，最低15.45元，成交额达3.33亿元，换手率为1.36%。近日，华兰生物工程股份有限公司发布公告称，其参股公司华兰安康生物股份有限公司收到国家药品监督管理局签发的阿达木单抗注射液境内生产药品注册上市许可《受理通知书》。本次注册申请受理不影响公司近期业绩，最终获批时间与结果存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","002007","BK0077","BK0239","BK0028","BK0185","BK0197"],"gpt_icon":0},{"id":"2602557437","title":"股市必读：华兰生物（002007）1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557437","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557437?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:41","pubTimestamp":1768156867,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，华兰生物报收于15.65元，上涨0.71%，换手率0.93%，成交量14.58万手，成交额2.28亿元。董秘最新回复投资者： 今年还会增加几个血浆采集站？交易信息汇总资金流向1月9日主力资金净流出574.73万元；游资资金净流出1075.1万元；散户资金净流入1649.83万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0185","BK0188","002007","BK0046","BK0077","BK0239","BK0197"],"gpt_icon":0},{"id":"2602912313","title":"股市必读：华兰生物（002007）1月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602912313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602912313?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:36","pubTimestamp":1767893774,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，华兰生物报收于15.54元，上涨0.84%，换手率0.79%，成交量12.38万手，成交额1.92亿元。董秘最新回复投资者： 华兰你能不能猛涨一下？未来，公司将进一步提高信息披露质量，保持稳定分红，积极传递公司内在价值，切实维护投资者利益。当日关注点来自交易信息汇总：1月8日主力资金净流入1121.45万元，显示主力对华兰生物的积极介入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900001040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0197","BK0028","BK0077","BK0188","002007","BK0046","BK0239"],"gpt_icon":0},{"id":"2601785354","title":"华兰生物：以扎实业绩支撑长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2601785354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601785354?lang=zh_cn&edition=full","pubTime":"2026-01-08 17:00","pubTimestamp":1767862839,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)01月08日在投资者关系平台上答复投资者关心的问题。投资者提问：股价五年下跌，请问公司对国家倡导的长期价值投资怎么看？公司符合国家这一倡导方向吗？华兰生物回复：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响。公司始终坚持稳健经营，持续提升核心竞争力，以扎实的业绩支撑公司长期价值。未来，公司将进一步提高信息披露质量，保持稳定分红，积极传递公司内在价值，切实维护投资者利益。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800026564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","002007","BK0046","BK0077","BK0185","BK0028","BK0197"],"gpt_icon":0},{"id":"2601029716","title":"股市必读：华兰生物（002007）12月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601029716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601029716?lang=zh_cn&edition=full","pubTime":"2026-01-05 02:51","pubTimestamp":1767552668,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，华兰生物报收于15.13元，下跌0.39%，换手率0.4%，成交量6.22万手，成交额9428.19万元。公司公告汇总关于参股公司完成股份制改造及更名的公告华兰生物工程股份有限公司于2025年12月31日发布公告，其参股公司华兰基因工程有限公司已完成股份制改造，企业类型变更为其他股份有限公司（非上市），并更名为华兰安康生物股份有限公司。华兰生物仍持有标的公司40%股份，实际控制人安康先生持有60%股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500000883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","002007","BK0188","BK0046","BK0197","BK0239","BK0077","BK0028"],"gpt_icon":0},{"id":"2600067650","title":"每周股票复盘：华兰生物（002007）华兰基因完成股改并更名","url":"https://stock-news.laohu8.com/highlight/detail?id=2600067650","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600067650?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:39","pubTimestamp":1767379152,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，华兰生物报收于15.13元，较上周的15.32元下跌1.24%。本周，华兰生物12月29日盘中最高价报15.33元。华兰生物当前最新总市值276.49亿元，在生物制品板块市值排名11/51，在两市A股市值排名706/5181。华兰生物仍持有标的公司40%股份，实际控制人安康先生持有60%股份。本次改制不涉及持股比例变化，有助于完善公司治理结构，提升经营管理效率，符合长远发展战略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0188","BK0239","BK0077","002007","BK0197","BK0185"],"gpt_icon":0},{"id":"2594823329","title":"华兰生物：从事血液制品、疫苗、基因工程产品研发生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2594823329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594823329?lang=zh_cn&edition=full","pubTime":"2025-12-25 16:42","pubTimestamp":1766652129,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物12月25日在投资者关系平台上答复投资者关心的问题。公司参股公司华兰基因工程有限公司主要开展创新药和生物类似药的研发、生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500022979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0028","BK0197","BK0185","BK0188","BK0046","BK0077","BK0239","002007"],"gpt_icon":0},{"id":"2594628034","title":"华兰生物：截至2025年12月20日共有14.9万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2594628034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594628034?lang=zh_cn&edition=full","pubTime":"2025-12-25 15:03","pubTimestamp":1766646204,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)12月25日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问截止到12月20日的最新股东人数是多少，谢谢！华兰生物回复：截至2025年12月20日，公司共有14.9万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500016713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0185","BK0028","BK0077","BK0197","BK0188","BK0046","002007"],"gpt_icon":0},{"id":"2591398692","title":"华兰生物(002007.SZ)参股公司地舒单抗注射液药品注册获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2591398692","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591398692?lang=zh_cn&edition=full","pubTime":"2025-12-15 12:27","pubTimestamp":1765772839,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰生物 发布公告，近日，公司参股公司华兰基因工程有限公司收到国家药品监督管理局签发的地舒单抗注射液境内生产药品注册上市许可申请《受理通知书》。地舒单抗通过抑制RANKL，强效抑制破骨细胞介导的骨吸收和骨破坏，从而有效预防和延迟上述骨相关事件的发生，是临床重要的肿瘤支持治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0188","BK0197","BK0185","BK0077","BK0046","002007","BK0239"],"gpt_icon":0},{"id":"2590599018","title":"华兰生物：2025年流感疫苗出口巴基斯坦、多米尼加","url":"https://stock-news.laohu8.com/highlight/detail?id=2590599018","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590599018?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:24","pubTimestamp":1765445052,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物12月11日在投资者关系平台上答复投资者关心的问题。公司疫苗是否有出海计划？公司始终坚守对疫苗质量控制与稳定性监测的高标准，提供质高价优的疫苗产品，让安心与信任成为连接每一份健康的坚实桥梁，为民众健康保驾护航。公司在深耕国内市场的同时，也加大海外市场的开拓，2025年公司流感疫苗先后出口到巴基斯坦、多米尼加等国家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100027922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0185","BK0046","BK0077","BK0197","BK0028","002007"],"gpt_icon":0},{"id":"2590599610","title":"华兰生物：公司经营一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2590599610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590599610?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:18","pubTimestamp":1765444689,"startTime":"0","endTime":"0","summary":"公司经营一切正常，主营业务稳步推进，核心生产、销售、研发等环节均有序开展，不存在应披露或未披露的不确定性风险。公司始终将提升核心经营能力作为市值管理的根本抓手，一方面聚焦主业深耕，持续优化产品结构、提升运营效率、加强成本管控，努力提升业绩夯实公司长期价值；另一方面严格按照监管要求履行信息披露义务，积极传递公司内在价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100027771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0185","BK0188","002007","BK0046","BK0077","BK0239","BK0197"],"gpt_icon":0},{"id":"2586642380","title":"华兰生物：截至2025年11月20日共有14.8万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2586642380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586642380?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:48","pubTimestamp":1764060496,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)11月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截至11月20日的股东人数是多少，谢谢华兰生物回复：截至2025年11月20日，公司共有14.8万多名投资者，谢谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500023574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0197","BK0077","BK0028","002007","BK0046","BK0185"],"gpt_icon":0},{"id":"2584189817","title":"华兰生物：2025年1-9月营收33.79亿元净利下降9.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584189817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584189817?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:15","pubTimestamp":1763626521,"startTime":"0","endTime":"0","summary":"华兰生物回复：2025年1-9月份，公司营业收入为33.79亿元，较上年同期下降3.2%，归属于上市公司股东的扣除非经常性损益的净利润为7.42亿元，较上年同期下降9.17%，主要原因之一是供求关系变化，血液制品价格较上年同期有所下降，血液制品业务的净利润较上年同期有所下降；二是公司控股子公司华兰疫苗营业收入和净利润较上年同期有所下降，随着四季度流感疫苗需求增加，流感疫苗销售收入增加，预计经营业绩会有所改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000020352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007"],"gpt_icon":0},{"id":"2584336229","title":"华兰生物（002007）公司公告补选第九届董事会独立董事及关联交易议案获通过，11月18日股价下跌1.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584336229","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584336229?lang=zh_cn&edition=full","pubTime":"2025-11-18 17:57","pubTimestamp":1763459844,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，华兰生物报收于16.2元，较前一交易日下跌1.34%，最新总市值为296.05亿元。近日，华兰生物发布2025年第三次临时股东会决议公告，披露公司已于2025年11月17日召开2025年第三次临时股东会，审议通过《关于补选第九届董事会独立董事的议案》和《关于授权关联方使用公司注册商标暨关联交易的议案》。两项议案均获得通过，其中涉及关联交易的议案已按规定履行关联股东回避表决程序。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800027808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0185","BK0028","BK0077","BK0197","BK0188","BK0046","002007"],"gpt_icon":0},{"id":"2584468296","title":"11月17日华兰生物现1笔大宗交易 机构净买入2463万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584468296","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584468296?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:23","pubTimestamp":1763371426,"startTime":"0","endTime":"0","summary":"证券之星消息，11月17日华兰生物发生大宗交易，交易数据如下：大宗交易成交价格16.42元，成交150万股，成交金额2463万元，买方营业部为机构专用，卖方营业部为中国国际金融股份有限公司上海分公司。近三个月该股共发生2笔大宗交易，合计成交2.8万手。截至2025年11月17日收盘，华兰生物报收于16.42元，下跌2.44%，换手率1.76%，成交量27.67万手，成交额4.58亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700022793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002007","BK0185","BK0077","BK0239","BK0197","BK0028","BK0046"],"gpt_icon":0},{"id":"2582339500","title":"股市必读：华兰生物（002007）11月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582339500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582339500?lang=zh_cn&edition=full","pubTime":"2025-11-12 01:04","pubTimestamp":1762880657,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，华兰生物报收于16.83元，上涨0.06%，换手率1.5%，成交量23.57万手，成交额3.95亿元。董秘最新回复投资者： 1、重组 Exendin-4-FC 融合蛋白注射液临床疗效及适用症？公司参股公司华兰基因工程有限公司已于 2024 年11 月22 日递交了利妥昔单抗注射液的上市申请，目前正在 CDE审评过程中。长期持股以来一直处于亏损状态，建议董秘给一个说法。当日关注点来自交易信息汇总：11月11日主力资金净流出4618.72万元，散户资金净流入4138.14万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200000747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0197","BK0046","BK0028","002007","BK0077","BK0185"],"gpt_icon":0},{"id":"2582887355","title":"华兰生物：2025年1-9月营收33.79亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582887355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582887355?lang=zh_cn&edition=full","pubTime":"2025-11-11 15:39","pubTimestamp":1762846772,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物11月11日在投资者关系平台上答复投资者关心的问题。2025年1-9月份，公司营业收入为33.79亿元，较上年同期下降3.2%，归属于上市公司股东的扣除非经常性损益的净利润为7.42亿元，较上年同期下降9.17%，主要原因系公司控股子公司华兰疫苗销售后移，收入和净利润下降较多，随着四季度流感疫苗销售收入增加，预计经营业绩会有所改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100020171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007"],"gpt_icon":0},{"id":"2582435586","title":"华兰生物：流感疫苗批签发54批","url":"https://stock-news.laohu8.com/highlight/detail?id=2582435586","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582435586?lang=zh_cn&edition=full","pubTime":"2025-11-11 15:39","pubTimestamp":1762846770,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物11月11日在投资者关系平台上答复投资者关心的问题。华兰生物回复：公司控股子公司华兰疫苗股份有限公司是国内最大的流感疫苗生产企业，具备年产1亿剂流感疫苗的生产能力，自2018年国内首家上市四价流感病毒裂解疫苗以来，凭借高质量的产品连续多年产、销量稳居国内前列，截止目前，公司2025年共批签发流感疫苗54批，其中四价流感病毒裂解疫苗批签发48批。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100020165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0188","BK0239","BK0077","002007","BK0197","BK0185"],"gpt_icon":0},{"id":"2581070042","title":"11月7日华兰生物现1笔大宗交易 机构净买入2139.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581070042","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581070042?lang=zh_cn&edition=full","pubTime":"2025-11-07 17:11","pubTimestamp":1762506699,"startTime":"0","endTime":"0","summary":"证券之星消息，11月7日华兰生物发生大宗交易，交易数据如下：大宗交易成交价格16.46元，成交130万股，成交金额2139.8万元，买方营业部为机构专用，卖方营业部为中国国际金融股份有限公司上海分公司。近三个月该股共发生1笔大宗交易，合计成交1.3万手。截至2025年11月7日收盘，华兰生物报收于16.46元，上涨0.92%，换手率1.19%，成交量18.74万手，成交额3.08亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700026902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0197","BK0046","BK0028","002007","BK0077","BK0185"],"gpt_icon":0},{"id":"2579483470","title":"华兰生物：加强流感疫苗产品推广工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2579483470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579483470?lang=zh_cn&edition=full","pubTime":"2025-10-31 09:01","pubTimestamp":1761872478,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)10月31日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘：1、流感季提前到来，日本、欧洲、我国南方地区都出现了大范围病毒传播与感染，目前公司所属疫苗能否满足需要？有否积极推广？出口情况如何？2、公司有否维护和加强市值管理措施，以什么方式来加强市值管理？华兰生物回复：公司将加强流感疫苗的产品推广工作，积极做好流感疫苗的销售工作，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100013310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0185","BK0197","BK0028","002007","BK0046","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768324589708,"stockEarnings":[{"period":"1week","weight":0.0142},{"period":"1month","weight":0.0275},{"period":"3month","weight":-0.0138},{"period":"6month","weight":-0.0022},{"period":"1year","weight":0.0519},{"period":"ytd","weight":0.0377}],"compareEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0641},{"period":"3month","weight":0.0579},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.3094},{"period":"ytd","weight":0.0428}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"148000人(较上一季度减少0.67%)","perCapita":"10633股","listingDate":"2004-06-25","address":"河南省新乡市红旗区华兰大道甲1号","registeredCapital":"182745万元","survey":"　　华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品研发、生产和销售。公司的主要产品是血液制品、疫苗制品、创新药和生物类似药。","listedPrice":15.74},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰生物,002007,华兰生物股票,华兰生物股票老虎,华兰生物股票老虎国际,华兰生物行情,华兰生物股票行情,华兰生物股价,华兰生物股市,华兰生物股票价格,华兰生物股票交易,华兰生物股票购买,华兰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}